Free Trial

Pieris Pharmaceuticals (PIRS) SEC Filings & 10K Form

$11.18
0.00 (0.00%)
(As of 05:26 PM ET)

Recent Pieris Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/09/2024
7:00 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
3:21 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
4:31 PM
Pieris Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/27/2024
7:00 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
12:12 PM
Checkpoint Capital L.P. (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
8:19 AM
Lynx1 Capital Management LP (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13G/A
02/02/2024
8:59 AM
Pieris Pharmaceuticals (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
Form SC 13G/A
12/21/2023
3:30 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
3:02 PM
Pieris Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/17/2023
3:49 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13D/A
07/18/2023
8:15 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2023
6:30 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
4:25 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
3:45 PM
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:45 PM
Pieris Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Sherman Matthew L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:45 PM
Pieris Pharmaceuticals (Issuer)
Pieris Pharmaceuticals (Issuer)
Said Maya R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:45 PM
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:45 PM
Pieris Pharmaceuticals (Issuer)
Richman Michael (Reporting)
Richman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:46 PM
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:46 PM
KIRITSY CHRISTOPHER P (Reporting)
KIRITSY CHRISTOPHER P (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:46 PM
Kiener Peter A (Reporting)
Kiener Peter A (Reporting)
Pieris Pharmaceuticals (Issuer)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:46 PM
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:46 PM
GERAGHTY JAMES A (Reporting)
GERAGHTY JAMES A (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:47 PM
Barbier Ann (Reporting)
Pieris Pharmaceuticals (Issuer)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
6:00 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2023
5:01 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2023
3:21 PM
KIRITSY CHRISTOPHER P (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
3:47 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13D
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PIRS) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners